Cardiol Therapeutics (CRDL) Operating Leases (2020 - 2026)
Cardiol Therapeutics' (CRDL) quarterly Operating Leases came in at $55868.8 in Q1 2026, down 31.13% YoY from $81126.7 in Q1 2025, and down 10.63% on a QoQ basis from $62512.7 in Q4 2025.
Cardiol Therapeutics (CRDL) Operating Leases (2020 - 2026) Analysis & Trends
Cardiol Therapeutics (CRDL) has 7 years of Operating Leases data on file, last reported at $55868.8 in Q1 2026.
- Quarterly Operating Leases fell 31.13% year-over-year to $55868.8 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $55868.8 (down 31.13% YoY) and the FY2025 annual result came in at $62512.7, down 30.43% from the prior year.
- Operating Leases fell to $55868.8 in Q1 2026, from $62512.7 in the prior quarter.
- In the past five years, Operating Leases ranged from a high of $116447.4 in Q4 2023 to a low of $6723.1 in Q1 2023.
- A 5-year average of $69858.1 and a median of $73952.2 in 2025 frame the typical range for Operating Leases.
- Annual changes were most pronounced in 2023 — Operating Leases sank 85.96% — and 2024, when it surged 1563.02%.
- Tracing CRDL's Operating Leases over 5 years: stood at $16519.8 in 2022, then jumped by 604.89% to $116447.4 in 2023, then fell by 22.84% to $89855.5 in 2024, then plunged by 30.43% to $62512.7 in 2025, then dropped by 10.63% to $55868.8 in 2026.
- The last three Operating Leases figures came in at $55868.8 (Q1 2026), $62512.7 (Q4 2025), and $70682.7 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Cardiol Therapeutics | 215.50 Mn | 196.65 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 55,868.82 |
| Dec 31, 2025 | 62,512.71 |
| Sep 30, 2025 | 70,682.69 |
| Jun 30, 2025 | 77,221.79 |
| Mar 31, 2025 | 81,126.65 |
| Dec 31, 2024 | 89,855.53 |
| Sep 30, 2024 | 98,375.03 |
| Jun 30, 2024 | 104,227.01 |
| Mar 31, 2024 | 111,806.78 |
| Dec 31, 2023 | 116,447.39 |
| Sep 30, 2023 | 113,485.86 |
| Mar 31, 2023 | 6,723.10 |
| Dec 31, 2022 | 16,519.83 |
| Sep 30, 2022 | 27,184.99 |
| Jun 30, 2022 | 37,800.51 |
| Mar 31, 2022 | 47,891.16 |
| Dec 31, 2021 | 57,811.19 |
| Sep 30, 2021 | 59,232.75 |
| Jun 30, 2021 | 69,357.26 |
| Dec 31, 2020 | 80,273.04 |